ACXP
ACXP
NASDAQ · Biotechnology

Acurx Pharmaceuticals Inc

$1.58
-0.10 (-5.95%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +1,148.1% upside
Low Target $18.07
Average Target $19.72
High Target $32.84
Current Price $1.58
Current
$1.58
Target
$19.72
$18.07 $19.72 avg $32.84
Scenario Analysis
Bear Case
$18.07
1,043.7%
Low target
Base Case
$19.72
+1,148.1%
Avg target
Bull Case
$32.84
+1,978.5%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$12.60
-87.5% from high
52-Week Low
$1.33
+19.2% from low
Target vs 52W High
$19.72
+56.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +1.3%
AMGN
Amgen Inc
Hold 44 50% $190.87 -47.1%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -12.3%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -65.1%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -40.8%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -47.5%